Low-dose naltrexone (LDN) and cannabinoids are discussed as options for managing chronic pain. Cannabinoids show modest relief, especially for neuropathic pain, while LDN may enhance their effects. Personal experiences highlight significant pain reduction without withdrawal symptoms. The importance of educating healthcare providers about LDN and exploring various treatments is emphasized. The conversation also addresses individualized treatment plans and the role of lifestyle in pain management.

Dr Saleeby is the Medical Director of two centers in South Carolina (Carolina Holistic Medicine) and founder of the Priority Health Academy (PHA) a non-profit educational arm of the practice.  

His Academy provides education and training in functional medicine/healing and assists those wishing to establish centers similar in the USA and Canada.  He is a clinical professor in functional medicine and biomedical ethics for the PHA. He is an avid warrior for medical freedoms and patient advocacy. Senior Fellow with the FLCCC and advisor and co-chair of the educational committee for the BODY Healthcare.

Advisor to the LDN Research Trust.

He retired from Emergency Medicine after 17 years to focus on a more holistic approach to patient care.  He is interested in medical history and lectures on topics related to the American Civil War.  

Dr. Saleeby is a member of medical organizations such as:  IFM, ILADS, AARM, ISEAI and in association and advisor to the BODY Healthcare, the LDN Research Trust, and the FLCCC